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Abstract
A worker developed angiosarcoma, porphyria
cutanea tarda, and skin lesions characteristic
of mild chloracne. About 10 years earlier he
had been employed at a truck terminal in
Saint Louis, Missouri, at a time when it was
sprayed with waste oil contaminated with
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
The occurrence of these three rare conditions
in a single exposed worker supports the aetio-
logical relation between environmental expo-
sure to TCDD and the subsequent
development of soft tissue sarcoma and por-
phyria cutanea tarda.
(British Journal ofIndustrial Medicine 1993;50:699-703)
Knowledge of the toxic effects of 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) in humans has
resulted primarily from clinical and epidemiological
studies of workers exposed during the manufacture
of chlorinated phenols or as the result of explosions
and industrial accidents. It is known that TCDD
causes chloracne.1 It causes a syndrome resembling
porphyria cutanea tarda in animals and is a sus-
pected cause of some cases of this in humans. It
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has also been implicated as a cause of toxic hepati-
tis, peripheral neuropathy, neuropsychiatric dis-
ease, increased susceptibility to infection, abnormal
lipid metabolism, and damage to the endocrine,
gastrointestinal, and cardiovascular systems.2
Minute doses of TCDD are carcinogenic in
rodents.3 In humans, TCDD has been implicated
as a cause of soft tissue sarcoma and malignant
lymphoma in some (but not all) epidemiological
studies.' Although no occupational exposure stan-
dard exists for TCDD, the National Institute for
Occupational Safety and Health (NIOSH) has
recommended that TCDD be regarded as a
potential occupational carcinogen, "that occupa-
tional exposure to TCDD be controlled to the
fullest extent feasible, and that decontamination
measures be used for TCDD contaminated work
environments."4
In Missouri in the early 1970s, oil contaminated
with TCDD was used for dust control on roads at
several residential and commercial sites. At some
sites, animal deaths and acute illness resulted
among exposed persons.5 Evaluation of workers
from the production plant where the TCDD origi-
nated and of residents of the contaminated com-
munities showed raised TCDD concentrations in
adipose tissue.6 Cell mediated immunity was
depressed.7 Mean urinary porphyrin concentrations
and liver enzyme activities were increased among
persons in the exposed community, and these
increases were attributed to subclinical hepatotoxic
effects.
In this communication we report the case of a
worker previously exposed in Missouri to oil conta-
minated with TCDD, who subsequently developed
a soft tissue sarcoma, porphyria cutanea tarda, and
probable chloracne. The preliminary evaluation of
this case has been reported elsewhere.8
Case description
A 59 year old white male truck driver was in good
health until the summer of 1981, when he saw his
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family physician for a rash that had appeared in
areas of his body that were exposed to the sun. The
rash resolved without specific treatment. During
the subsequent summer he experienced blistering
and increased hair over the dorsa of his hands.
Biopsy of a bulla revealed a subepidermal blister
with moderately intense perivascular lymphocytic
infiltrate in the underlying superficial dermis, con-
sistent with porphyria cutanea tarda. A laboratory
evaluation (table) confirmed the diagnosis of por-
phyria cutanea tarda. In particular, urinary uropor-
phyrin, 7-carboxylate porphyrin, and faecal
isocoproporphyrin were noticeably increased. As
expected in this disease, plasma porphyrins were
increased and urinary (-aminolevulinic acid and
porphobilinogen were normal. A liver and spleen
scan showed a normal sized liver. There was mild
inhomogeneity in distribution of sulphur colloid
Results of laboratory measurements related to porphyria in the
patient
Normal range or
Measurement Patient pattern
Total urinary 3432 0-300
porphyrins
(nmol/24 h)
Chromatographic Uroporphyrin 1885; Predominantly
pattern 7-carboxylate coproporphyrin
porphyrin 1224;
6-carboxylate
porphyrin 98;
5-carboxylate
porphyrin 58;
coproporphyrin 37.
Urinary 8- 2-5 0-7
aminolevulinic
acid (mg/24 h)
Urinary 0-7 0-4
porphobilinogen
(mg/24 h)
Plasma 17-7 Undetectable
porphyrins (ug/dl)
Total faecal 149 0-100
porphyrins (nmol/g
dry weight)
Chromatographic Isocoproporphyrin, Protoporphyrin,
pattern (in protoporphrin, coproporphyrin.
decreasing coproporphyrin,
amounts) 7-carboxylate
porphyrin,
6-carboxylate
porphyrin,
5-carboxylate
porphyrin.
Erythrocyte 87 81-9 (18-1)*
uroporphyrinogen
decarboxylase(nmol/ml/h)
*Mean (SD).
Total urine porphyrins, individual urinary porphyrins, and ery-
throcyte uroporphyrinogen decarboxylase were measured as
described previously.27282' Total plasma porphyrin content was
measured by extraction with ethyl acetate/acetic acid 2:1 (v/v); the
organic phase was extracted with 0 5 N HCI and the maximum
fluorescence peak was measured (excitation wavelength 400 nm).
Total faecal porphyrins were measured by a modification of the
method of Rimington," where the final ether phase was extracted
with 0-6 N HCl and diluted with 1 N perchloric acid/methanol,
1:1 (v/v) for fluorescence measurement. Thin layer chromatogra-
phy of faecal porphyrins was performed as described by Smith.3'
with mild shift to the spleen, consistent with mild
hepatocellular disease. Liver function tests and
liver enzymes were normal, although the patient
previously had abnormal liver enzymes in 1981
(y-glutamyl transferase 75 IU/l (normal 0-65),
alanine aminotransferase 76 IU/l (normal 0-45),
aspartartate aminotransferase 36 IU/l (normal
0-41). The patient's symptoms improved with
phlebotomy, cessation of his previous weekly con-
sumption of one case of beer, and avoidance of
sun, although hypertrichosis persisted and spread
to his face, and occasional bullae recurred. Blood
uroporphyrinogen decarboxylase was normal in the
patient (table), as well as in six of his first degree
relatives. There was no family history of porphyria
cutanea tarda or inborn errors of porphyrin
metabolism.
Because of right leg weakness and pain, a com-
puted tomography scan of the pelvis was done in
February 1983, revealing multiple lytic lesions of
the bony pelvis and proximal right femur with
involvement of soft tissue. An open biopsy of the
right iliac wing showed an angiosarcoma. A stain
for factor VIII associated antigen was positive. The
patient died in September 1984 as a result of this
tumour.
Between August 1982 and December 1983 the
patient lost 66 pounds. During this time he
reported that he developed an acneiform rash on
his face. On examination in December 1983 he had
numerous open comedones and comedonal cysts
over both malar crescents, periorbital crow's feet,
and over the sides of the nose with blackheads,
cobblestoning, and cysts. He also had several open
comedones behind both ears. A skin biopsy showed
actinically damaged skin with mild epithelial dys-
plasia, prominent solar elastosis, and increased
mucinous deposition within the dermal connective
tissue. There were also multiple comedones, most
of which were associated with large sebaceous
units. Comedones seemed to be loosely packed
with keratin and a variety of organisms. Electron
micrographs showed normal superficial and follicu-
lar epithelium and normal sebaceous glands, which
contained large sebaceous cells with fat globules.
There were no photomicrographs that included
portions of a comedone. Although the patient did
not recall a history of acne in earlier years or in
childhood, his daughters reported that he had
blackheads and pimples under his eyes as early as
April 1972.
The patient worked driving a truck within St
Louis from 1962 to January 1981 for a truck termi-
nal that was subsequently found to be contami-
nated with TCDD. Analysis of soil samples at the
site conducted by the United States Environmental
Protection Agency in early 1983, about 10 years
after spraying, showed concentrations ofTCDD up
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to 17 parts per billion. This site was one of several
truck terminals in St Louis believed to have been
contaminated with TCDD by the application of
waste oil for dust control. The contaminated oil
was applied by a single company. Workers at the
site reported that the terminal lot was covered with
oil, leaving large pools in the lot after spraying. The
contaminated oil is thought to have been applied
during the early 1970s, although the exact dates
this terminal was sprayed with TCDD are not
known. During this period the patient recalled
spending two to three months each year working
on the terminal lot as a "spotter", a worker who
hooks and unhooks trailers from trucks in the
sprayed area of the terminal. He reported that his
feet, legs, hands, and arms often became covered
with oil from the terminal lot while doing this job.
He had to have a separate pair of boots for this
work. Also, the patient worked as a driver making
pick ups and deliveries to the terminal one to three
times daily. He continued to work as a driver and,
intermittently, to work in the terminal lot into early
1980, during which time he may have had expo-
sure to TCDD bound to dust. The patient proba-
bly had less exposure at this time, because heavy
truck traffic in the lot would have resulted in
decreasing dioxin concentration in years subse-
quent to its application. There was no history of
exposure to herbicides, fungicides, other halo-
genated aromatics, or to oestrogens.
A sample of adipose tissue sent to a private labo-
ratory was anecdotally reported first as without
TCDD, then as positive. Despite repeated
inquiries, no written report was ever provided by
the laboratory.
Discussion
The constellation in this patient of soft tissue sar-
coma, porphyria cutanea tarda, and probably chlo-
racne, three rare conditions previously associated
with exposure to TCDD, is striking, particularly in
view of the patient's potentially heavy exposure to
TCDD. It is highly unlikely that these three ill-
nesses would coincide by chance alone. The annual
age adjusted incidence of soft tissue sarcoma in the
general population of the United States is only
5-6/100 000.9 It has been suggested that the preva-
lence of porphyria cutanea tarda is only 1/25 000.10
This patient was one of only two workers (of 328
who participated in a survey of truck terminal
workers) who had a skin condition suggestive of
chloracne. Chloracne is considered pathognomic of
exposure to certain halogenated hydrocarbons,
among which TCDD is the most potent. This case
suggests that the clinical manifestations of por-
phyria cutanea tarda and the recurrence of chlo-
racne may occur with a latency of many years after
exposure to TCDD.
Convincing evidence for a causal relation
between TCDD exposure and soft tissue sarcoma
comes from a cohort mortality study of United
States chemical plant workers exposed to TCDD."
A standardised mortality ratio (SMR) of 338 for
soft tissue sarcoma was found (SMR 922 in the
group with over 20 years of latency). Another large
cohort mortality study of workers exposed to phe-
noxy herbicides and chlorophenols also showed a
twofold increased risk of soft tissue sarcoma, which
increased to a ninefold statistically significant risk
when the analysis was restricted to sprayers, but
which was not specifically associated with exposure
to those herbicides most likely to have been conta-
minated with TCDD.12 Case-control studies con-
ducted in northern, central, and southern Sweden
have shown a two to sixfold increase in the risk of
death from soft tissue sarcoma, primarily among
workers with histories of occupational exposures to
TCDD contaminated phenoxy acid herbicides or
chlorophenols. It has been suggested that the
absence of a consistently increased risk in other
case-control studies may depend on differences in
genetic susceptibility for different groups, in
amounts of TCDD contaminants in the pesticides,
or in intensity of exposure because of differences in
the spray seasons in different parts of the world."3
Other epidemiological studies have been inconclu-
sive because of poor characterisation of exposure,
inadequate latency, or small study populations and
consequent low statistical power.
This worker's peak exposure to TCDD would
have occurred eight to 10 years before his first
recorded visit to a physician for porphyria cutanea
tarda. Although in previous reports porphyria
cutanea tarda among heavily exposed workers
occurred near the time of exposure,'415 the meta-
bolic defect can be long lasting. Persistent uropor-
phyrinuria was seen in one worker previously
exposed to TCDD and affected with porphyria
cutanea tarda about six years earlier.'6 Several
workers previously exposed in another factory, who
had normal urinary porphyrins, had liver tissue flu-
orescence suggestive of hepatic porphyria. 17
Persistent porphyrinuria was seen after 30 years in
some workers who developed porphyria from expo-
sure to hexachlorobenzene, another environmental
contaminant capable of causing porphyria cutanea
tarda.'8 In rodents hepatic porphyria induced by
TCDD persisted for at least six half lives after dos-
ing with TCDD ended, and one animal first devel-
oped uroporphyrinuria only after dosing stopped.'9
Porphyria cutanea tarda occurs when there is
pronounced deficiency of uroporphyrinogen decar-
boxylase in the liver, and leads to increased excre-
tion of uroporphyrin (8-carboxylate porphyrin),
7-carboxylate porphyrin, 6-carboxylate porphyrin,
5-carboxylate porphyrin, and isocoproporphyrins.
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The finding of increased faecal isocoproporphyrins
(formed from excess 5-carboxylate porphyrinogen
by the action of coproporphyrinogen oxidase,
another haem pathway enzyme) is definitive evi-
dence for a deficiency of hepatic uroporphyrinogen
decarboxylase.'0 Multiple environmental factors
can contribute to clinical expression in all forms of
porphyria cutanea tarda. In this patient, for exam-
ple, alcohol consumption and other chemicals that
may have been in the contaminated oil could have
contributed. Erythrocyte uroporphyrinogen decar-
boxylase activity was normal in the patient and in
his first degree relatives, which indicates that he did
not have the inherited (autosomal dominant) form
of porphyria cutanea tarda known as type I.21
Thne distribution of open and closed comedones
at the time of examination in 1983 (behind the ears
and over the malar areas) is characteristic of mild
chloracne.22 Although this patient did not remem-
ber acneiform lesions before 1983, he was reported
by his daughters to have had them as early as 1972
(during the time he would likely have been most
exposed to TCD contaminated waste oil). Almost
half of workers who have had chloracne have been
found to have residual blackheads and recurring
cysts up to 10 years after the workers considered
themselves clear of disease.22 It has been suggested
that this continued appearance of lesions after
exposure has ceased may result from release of
TCDD from fat.' In this patient chloracne would
have been likely to recur during 1983 as a result of
mobilisation ofTCDD from fat during the massive
tumour induced weight loss this patient experi-
enced. Mobilisation and concentration of TCDD
during weight loss in monkeys23 and acute toxicity
as a result of starvation induced mobilisation of
chlorinated hydrocarbon insecticides from fat in
rodents are animal models for this effect.24
Although the histopathological appearance of the
biopsy was suggestive of solar elastosis in an acne
prone individual, the differentiation from chloracne
based on histopathological criteria alone is
difficult.' Skin biopsy is less sensitive than clinical
examination of skin in the diagnosis of residual
chloracne.2' A biopsy reflects a small sample, and
solar elastosis has been reported to be more com-
mon and more severe among workers with chlo-
racne from TCDD.26
This case supports the aetiological relation
between environmental exposure to TCDD and
the subsequent development of soft tissue sarcoma
and porphyria cutanea tarda. It suggests that por-
phyria cutanea tarda and the recurrence of chlo-
racne may occur with a latency of many years after
exposure to TCDD.
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